5 Year Evolution of PCI vs CABG in Large Randomized Studies on Acute and Chronic Coronary Syndrome

Left main lesions in acute coronary syndrome (ACS) represent a major risk and, at present, the best revascularization strategy is a matter of debate. Though many studies and registries have excluded this group of patients, there is data on the pros and cons of both percutaneous coronary intervention (PCI) and cardiac artery bypass graft (CABG). 

Evolución a 5 años de la angioplastia vs cirugía en los grandes estudios sobre síndromes agudos y crónicos

This analysis looked at 4 randomized studies comparing PCI with drug eluting stents (DES) vs. CABG (SYNTAX, PRECOMBAT, NOBLE and EXCEL) including a total of 1,466 patients (33.4%) with SCA and 2,927 without SCA (NSCA).

Primary end point was all cause mortality at 5 years. Mean age was 65 and most patients were men. There were no significant differences between the groups, except for a higher prevalence of diabetes, prior MI, ejection fraction <50 and higher SYNTAX score, among SCA patients (26.4 vs. 25.2; p < 0.001).

Time from randomization to procedure was shorter in patients undergoing PCI.

At 30 days, there was higher cardiovascular and non-cardiovascular mortality in SCA patients vs. NACS (1.8 vs. 0.5 p<0.001 AND 1.9 vs. 0.5 p<0.001 respectively).

MI rate was higher in ACS patients both at one and five year followup (2.3% vs. 1.0%; HR 2.73, 95% CI ;1.63-4.58; p < 0.001 and 5.7% vs. 3.8%; HR 1.70, 95%CI: 1.25-2.31; p < 0.001, respectively).

Read also: Minimal Stent Area: New IVUS Parameter?

MI rate was higher in ACS patients both at one and five year followup (2.3% vs. 1.0%; HR 2.73, 95% CI ;1.63-4.58; p < 0.001 and 5.7% vs. 3.8%; HR 1.70, 95%CI: 1.25-2.31; p < 0.001, respectively).

Primary end point resulted similar with PCI for both ACS and NACS patients (10.9% vs 11.5% HR, 0.93; 95% CI, 0.68-1.27 and 11.3%vs 9.6% HR, 1.19; 95% CI, 0.95-1.50 respectively). There was a lower rate of stroke in the PCI group, but this group also showed higher need for repeat revascularization or MI vs. CABG patients. 

Conclusion

Among patients undergoing left main revascularization with low to intermediate coronary anatomical complexity, patients presenting ACS had a higher rate of early mortality. However, 5-year mortality was similar between PCI and CABG. In the short term, PCI had a relative advantage over CABG in terms of stroke. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Percutaneous Coronary Intervention vs Coronary Artery Bypass Graft Surgery for Left Main Disease in Patients With and Without Acute Coronary Syndromes. A Pooled Analysis of 4 Randomized Clinical Trials

Reference: Prakriti Gaba, et al. JAMA Cardiol. doi:10.1001/jamacardio.2023.1177.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

Rotational atherectomy and its technical secrets: use of floppy or ES guidewire

Rotational atherectomy (RA) remains a very useful tool in the management of severe coronary calcification. However, many of its technical aspects rely more on...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...